Akari Therapeutics PLC (AKTX)
3.16
+0.11
(+3.61%)
USD |
NASDAQ |
Jun 14, 16:00
3.16
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Stock Buybacks (Quarterly): -1.726M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.726M |
| June 30, 2023 | -0.2898M |
| March 31, 2023 | -3.212M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -12.37M |
| December 31, 2021 | -1.116M |
| September 30, 2021 | -11.18M |
| June 30, 2021 | -1.994M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -5.992M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -9.176M |
| March 31, 2020 | -9.878M |
| December 31, 2019 | -2.776M |
| September 30, 2019 | -8.398M |
| June 30, 2019 | -1.316M |
| March 31, 2019 | -0.1577M |
| December 31, 2018 | -0.1534M |
| September 30, 2018 | -0.3466M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -15.67M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -75.00M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -3.454M |
| September 30, 2014 | -0.2371M |
| June 30, 2014 | 8.219M |
| March 31, 2014 | -8.219M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-12.37M
Minimum
Mar 2022
--
Maximum
Sep 2020
-4.339M
Average
-2.385M
Median
Stock Buybacks (Quarterly) Benchmarks
| DBV Technologies SA | 0.062M |
| Cellectis SA | 0.00 |
| Adaptimmune Therapeutics PLC | -29.16M |
| Biodexa Pharmaceuticals Plc | -- |
| Verona Pharma PLC | 0.00 |